Bridgeway Capital Management, LLC Alx Oncology Holdings Inc Transaction History
Bridgeway Capital Management, LLC
- $4.76 Billion
- Q1 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 20,000 shares of ALXO stock, worth $112,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 33,500
40.3%
Holding current value
$112,000
Previous $498,000
55.22%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ALXO
# of Institutions
115Shares Held
38.4MCall Options Held
132KPut Options Held
19.7K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$54.3 Million42.27% of portfolio
-
Redmile Group, LLC San Francisco, CA4.33MShares$24.2 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.22MShares$23.6 Million6.29% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.14MShares$17.6 Million2.02% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.72MShares$15.2 Million0.68% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $228M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...